The Regence Group Medical Policy Manual Table of Contents

Search:

» Medical Policy

» Medication Policy

» Dental Policy

» Behavioral Health Policy

» Clinical Position Statements

» ConsumerTx

Browse alphabetically for topics addressed in TRG Medical Policies:
A	B	C	D	E
F	G	H	I	J
K	L	M	N	O
P	Q	R	S	T
U	V	W	X	Y
Z

Index

Please note: We are continually adding items to improve this index. If you are unable to find the term you are looking for, may we suggest you use the search engine at the top of this page to conduct a search for the term.

Last updated: (November 1, 2009)

Waldenström's macroglobulinemia; allogeneic

Waldenström's macroglobulinemia; autologous

Wallis® Mechanical Normalization System

Warfarin testing

Warm-up active wound therapy

Watch PAT; Actigraphy

Wheelchairs

Whole body dual x-ray absorptiometry, body composition

Wilm's tumor; allogeneic

Wilm's tumor; autologous

Wingspan™ Stent System

Wireless capsule endoscopy

Wireless pressure sensor; aneurysm

Wiskott-Aldrich syndrome; allogeneic

Wound healing, growth factors

Wound healing, noncontact ultrasound

Wound therapy, warm-up active wound therapy

Wounds, electrical stimulation

Comments from physicians and other health care practitioners regarding TRG medical policies are welcome. If you are a physician and have a question or comment regarding a medical policy, please contact the medical policy staff through our secure form.


	The Blue Cross and/or Blue Shield Plans comprising The Regence Group serve Idaho, Oregon, Utah and much of Washington state. The Regence Group and each of its affiliate Plans are independent licensees of the Blue Cross and Blue Shield Association.